Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
COVID-19 illness was virtually prevented in hamsters administered BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2 Data further strengthens value proposition of BiondVax’s...
-
New York, USA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Gum Turpentine Oil Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Gum Turpentine Oil Market...
-
New York US, Jan. 23, 2023 (GLOBE NEWSWIRE) -- According to a comprehensive research report by Market Research Future (MRFR), Off-Grid Solar Market Research Report Information by Application,...
-
TORONTO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hotspex Media has been named one of the Ad Age Best Places to Work 2023, an annual ranking of companies that lead the pack in factors ranging from pay and...
-
French company is a leading manufacturer and online seller of domestic appliances and cookware GXO and Groupe SEB have been partners in the U.K. since 2008 LONDON, U.K., Jan. 23, 2023 ...
-
Grundet lokale børslukkedage har Investeringsforeningen PortfolioManager anmodet om suspension af handel af følgende afdeling: Afdeling i Investeringsforeningen...
-
Selskabsmeddelelse nr. 01/2023Peberlyk 4DK-6200 AabenraaTelefon +45 74 37 37 37Telefax +45 74 37 35 36Sydbank A/SCVR-nr. DK 12626509, Aabenraasydbank.dk23. januar 2023 Forventningerne til...
-
Company Announcement 01/2023Peberlyk 46200 Aabenraa, DenmarkTel +45 70 10 78 79Fax +45 74 37 35 36Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk23 January 2023 Dear Sirs Expectations for...
-
Newton Biocapital II mène une ronde de financement pour le premier médicament de sa catégorie traitant la résistance à l'insulinePremière percée contre la résistance à l'insuline dans le traitement du...
-
Newton Biocapital II Leads Funding Round For First-of-Its-Kind Drug to Treat Insulin ResistanceFirst Breakthrough Addressing Insulin Resistance in Type 2 Diabetes TreatmentSTRASBOURG, France,...